![Michael Petruny](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Petruny
Nessuna posizione attualmente
Profilo
Michael Petruny worked as a Director-Immunology Sales at Fujisawa Healthcare, Inc., a Regional Manager at Enzon Pharmaceuticals, Inc., and a Vice President-Sales at Cylex, Inc. He received undergraduate and graduate degrees from Louisiana State University.
Precedenti posizioni note di Michael Petruny
Società | Posizione | Fine |
---|---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Vendite & Marketing | 18/11/2013 |
ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Fujisawa Healthcare, Inc. | Vendite & Marketing | - |
Formazione di Michael Petruny
Louisiana State University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ENZON PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Health Technology |
Fujisawa Healthcare, Inc. |
- Borsa valori
- Insiders
- Michael Petruny